YD Bio Ltd

YDES, YDESW · CIK 0002011674 · other

$0.75-10.71%Last updated Mar 2, 8:48 PM

OverviewFinancial Statements Valuation Models

Key Statistics

Valuation

Market Cap—

P/E—

Fwd P/E—

PEG—

P/S—

P/B0.16

EV/EBITDA—

EV/Rev—

Profitability

Gross Margin—

Op. Margin—

Net Margin—

ROE—

ROA—

FCF Margin—

Financial Health

Current Ratio—

Debt/Equity—

Free Cash Flow—

Div. Yield—

Growth & Other

Revenue Growth—

EPS Growth—

Beta0.17

52W High$0.75

52W Low$0.75

About YD Bio Ltd

YD Bio Ltd (YDESW) is a services-medical laboratories company incorporated in Cayman Islands, listed on the Nasdaq. The stock currently trades at $0.75, down 10.71% today, with a 52-week range of $0.83–$0.85.

Latest News

YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory PlatformYahoo Finance · Feb 25, 2026
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell TherapyYahoo Finance · Jan 29, 2026
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations.Yahoo Finance · Jan 13, 2026
YDES is A Biotechnology Company on the MoveYahoo Finance · Jan 7, 2026
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug DevelopmentYahoo Finance · Jan 6, 2026
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial RoadmapYahoo Finance · Jan 5, 2026
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations CenterYahoo Finance · Dec 16, 2025
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWANYahoo Finance · Dec 9, 2025
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early DetectionYahoo Finance · Dec 2, 2025
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome TherapeuticsYahoo Finance · Nov 24, 2025

Annual Reports (10-K) · 0 filings

No 10-K filings found.